Thursday 24 Jan 2013
Outsourcing firm Mitie said it was performing in line with management expectations as strong organic growth was driven by new and expanded contracts.
Thursday 24 Jan 2013
Credit Suisse has hiked its target price for easyJet from 884p to 1,000p after raising its full-year profit forecasts following the budget airline operator's first-quarter results.
Thursday 24 Jan 2013
UK stocks opened broadly flat on Thursday morning as a disappointing earnings report from the world's largest technology company weighed on sentiment early on.
Thursday 24 Jan 2013
Engineering and software group Invensys reiterated that the completion of its rail disposal to Siemens should happen in the second quarter of 2013, as it continues to wait for the all-clear by regulators.
Thursday 24 Jan 2013
If there is one thing the market likes is a company whose sales are growing at an accelerating rate. Unfortunately for Apple, its revenues are now growing at a decelerating pace.
Wednesday 23 Jan 2013
ICAP, the world’s largest interdealer broker, has reportedly become a focus of the UK Libor rate-rigging investigation and is being investigated by the Financial Services Authority for possible breaches of market conduct rules. The UK financial watchdog has asked seven of around 50 people working on its London Interbank Offered Rate investigation to focus on ICAP, according to an internal FSA
Wednesday 23 Jan 2013
Total revenue for the first quarter ending December 31st rose 9.2 per cent to 833m pounds at low-cost airline company easyJet, according to an interim management statement issued by the company on Thursday morning.
Wednesday 23 Jan 2013
Lloyds Banking Group confirmed Wednesday it would slash a further 940 jobs as part of plans to turn its business around.
Wednesday 23 Jan 2013
Deutsche Bank has trimmed its fourth-quarter forecasts for B&Q and Screwfix owner Kingfisher on the back of a negative read-across from peers in the DIY retail industry.
Wednesday 23 Jan 2013
After a weak start, the dollar retained gains against most major currencies as a short-term extension was approved for the US debt ceiling.
Tuesday 22 Jan 2013
Rio Tinto is said to be looking at options for its Mozambique business after it was forced to write down the value of the unit by a whopping three billion dollars.
Tuesday 22 Jan 2013
Markets were volatile in morning trade on Tuesday as traders reacted to mixed newsflow from Germany, though stocks remained in negative territory following an underwhelming policy announcement from Japan.
Tuesday 22 Jan 2013
The name of Tate&Lyle ought perhaps to be changed, argues The Times’s Tempus on Wednesday morning. This is because with each passing day traditional sugar is less and less what it does. Thus, about 55% of profits now come from Specialty Food Ingredients (SFI), mainly sweeteners and starches, that go into processed foods. The rest is from processing corn into fructose for soft drinks and so on.
Tuesday 22 Jan 2013
While Credit Suisse has retained an 'overweight' position in UK equities, the broker has trimmed its position to pay for its recent upgrade to Japan and picked out 'what to buy' in its London-listed coverage.
Tuesday 22 Jan 2013
The ZEW Indicator of Economic Sentiment for Germany increased by 24.6 points in January to 31.5 points, thereby reaching its highest level since May 2010.
Tuesday 22 Jan 2013
UK stocks opened slightly lower on Tuesday morning after the Bank of Japan's (BoJ) policy announcement overnight failed to live up to expectations.
Tuesday 22 Jan 2013
Pascal Perrier has sold 30,000 ordinary shares of 5pence each in Burberry for 1366.8 pence, according a statement issued by the company on Wednesday morning.
Tuesday 22 Jan 2013
Online food company Ocado has unveiled Sir Stuart Rose, who was formerly the Executive Chairman of the British retailer Marks & Spencer, as its new independent Non-Executive Director and Chairman Designate, effective from March 11th.
Tuesday 22 Jan 2013
Crude oil futures nursed their steepest decline in a month on Wednesday as traders looked ahead to weekly inventory data, with many forecasting a glut in supplies.
Tuesday 22 Jan 2013
Health insurers and doctors in the United States are turning up their noses at AstraZeneca’s much-vaunted new heart drug, according to a leading broker. Analysts at Société Générale forecast yesterday that sales of Brilinta would reach only 304 million dollars by 2015 — barely a third of the market’s consensus of 891 million dollars.
You are here: news > editors picks